Endotoxin opens the tollgates to innate immunity

Nature Medicine

Volumn 5, Issue 2, 1999, Pages 144-145

  Ulevitch, Richard J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CD14 ANTIGEN; ENDOTOXIN; LIPOPOLYSACCHARIDE; RECEPTOR;

CELL ACTIVATION; GENETICS; IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; SHORT SURVEY; SIGNAL TRANSDUCTION; TOXIN STRUCTURE;

ANIMALS; DROSOPHILA PROTEINS; DRUG RESISTANCE; IMMUNITY; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MICE; MUTATION; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTORS;

EID: 0032938004     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/5504     Document Type: Short Survey

References (10)

1. Thomas, L. The Lives of a Cell. Notes of a Biology Watcher. (The Viking Press, New York, 1974).
2. Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282, 2085-2088 (1998).
3. Kirschning, C.J., Wesche, H., Ayres, T.M. & Rothe, M. Human Toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J. Exp. Med. 188, 2091-2097 (1998).
4. Yang, R.B. et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 17, 284-288 (1998).
5. Ulevitch, R.J. & Tobias, P.S. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13, 437-457 (1995).
6. Medzhitov, R. & Janeway, C.A., Jr. Self-defense: The fruit fly style. Proc. Natl. Acad. Sci. USA 95, 429-430 (1998).
7. Williams, M.J., Rodriguez, A., Kimbrell, D.A. & Eldon, E.D. The 18-wheeler mutation reveals complex antibacterial gene regulation in Drosophila host defense. EMBO J. 16, 6120-6130 (1997).
8. Pugin, J. et al. CD14 is a pattern recognition receptor. Immunity 1, 509-516 (1994).
9. Kuhns, D.B., Long Priel, D.A. & Gallin, J.I. Endotoxin and IL-1 hyporesponsiveness in a patient with recurrent bacterial infections. J. Immunol. 158, 3959-3964 (1997).
10. Schimke, J., Mathison, J., Morgiewicz, J. & Ulevitch, R.J. Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin. Proc. Natl. Acad. Sci. USA 95, 1 3875-1 3880 (1998).